ATPW
XPH icon

Ashton Thomas Private Wealth’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Ashton Thomas Private Wealth’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6K Sell
326
-25
-7% -$1.47K ﹤0.01% 1436
2026
Q1 		$19K Buy
+351
New +$19.6K ﹤0.01% 1356

Other funds holding XPH

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
EP
Evelyn Partners London $46.9B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Ashton Thomas Private Wealth's XPH Position: Q2 2026 in Review

Ashton Thomas Private Wealth reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 7.1% in Q2 2026, selling an estimated $1.47K and leaving 326 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Ashton Thomas Private Wealth first reported a position in XPH in Q1 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

  • Ashton Thomas Private Wealth held 326 shares of State Street SPDR S&P Pharmaceuticals ETF worth $21.6K as of Q2 2026.
  • Ashton Thomas Private Wealth sold 25 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $1.47K.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #1436 holding.
  • Ashton Thomas Private Wealth first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2026 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.